Duolingo’s Folly: A Comedy of Errors

Behold, then, Duolingo, a company which purports to impart the gift of tongues through a digital device. A laudable ambition, one might think. Yet, it finds itself beset by a most modern of anxieties: the advent of Artificial Intelligence. It appears the very tool meant to augment human intellect threatens to render obsolete the need for diligent study. A paradox, is it not? The public now wonders if a mere application is necessary when the power of instant translation resides within a machine.

Vertiv: A Backlog’s Weight

Vertiv, a name perhaps unfamiliar to those captivated by the glittering facade of AI, provides the very sinews that bind these digital cathedrals together. They traffic not in code, but in kilowatts, in precisely calibrated airflow, in the intricate ballet of thermal regulation. And lately, the whispers emanating from their order books suggest a demand so substantial it borders on the unsettling. A backlog, they report, of fifteen billion dollars. A sum that speaks not of simple growth, but of a systemic reliance, a dependence verging on the precarious.

Market Valuation & The Weight of Years

Recent performance, indeed, has been…remarkable. The S&P 500 index, a barometer of collective optimism and, let us not forget, collective delusion, has delivered a total return of 300% over the past decade. A figure that compels attention, though one must ask: at what cost, and for how long can such a trajectory be sustained?

Brunswick’s CEO & a Rather Large Sale

(Just so we’re clear, that transaction value is based on the SEC Form 4 weighted average purchase price of $86.56. The post-transaction value uses the market close on February 5th, 2026, also $86.56. Precise, aren’t we?)

SaaS Apocalypse? Honestly…

They’re calling it the “SaaSpocalypse.” Dramatic, isn’t it? Like a biblical plague, only with more subscription fees. The question isn’t whether it’s going to end, it’s why it started. And frankly, the answer is deeply unsettling. It’s not about the economy; it’s about… efficiency. The sheer audacity of it all.

NuScale: A Reactor for Our Times

Oregon’s NuScale Power, a name whispered with a mixture of hope and skepticism, proposes a solution. Small Modular Reactors, they call them – SMRs. Compact, scalable, and, crucially, potentially profitable. One imagines them as miniature suns, capable of illuminating not just our homes, but the insatiable data centers that house the digital ghosts of our ambitions. A rather Faustian bargain, wouldn’t you agree? Trading one form of potential catastrophe for another, all in the name of progress.

Cytokinetics: A Soul’s Reckoning

The figures themselves are mere shadows, obscuring the true drama. This was no simple divestment, but a calculated severing – a parting with holdings significantly larger than his recent inclinations, a thinning of the protective layer between man and the abyss of potential loss. He now holds but a fragment of his former dominion, a mere 0.04% of the total shares outstanding. A humbling reduction, is it not? One wonders if this is prudence, or a premonition of darker days to come.

Buffett’s Picks: Buy, Hold, and Oy Vey!

Now, listen closely. Apple and American Express? Dependable. Solid. Like your bubbe’s chicken soup. Kraft Heinz? Forget about it! That’s a mess. A total, unmitigated disaster. We’ll get to that later. Trust me, you’ll want to sit down for that one.

American Express: A Dividend, Not a Revelation

The company, catering to those who mistake spending for living, enjoys a certain resilience. It is a haven for the affluent, a demographic that, while often lacking in taste, rarely lacks funds. This, of course, is the true security, not some fanciful notion of inherent value. One should always invest in the habits of others, not their virtues.

Lilly’s Ascent: A Potion Worth the Price?

However, even with this minor setback, Lilly remains… expensive. Trading at 43 times its recent earnings, it’s priced as if it holds the secret to eternal youth – or at least, a very effective remedy for indigestion. The S&P 500, by comparison, is practically giving its earnings away. The question, then, is whether this premium is justified, or if a patient investor might be better served by waiting for a more… favorable moment.2